329 related articles for article (PubMed ID: 16599060)
1. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Bar-Natan M; Nagler A
Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
[No Abstract] [Full Text] [Related]
2. [Posttransplant lymphoproliferative disorder].
Oike F; Egawa H; Haga H; Kudo T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():639-46. PubMed ID: 16615551
[No Abstract] [Full Text] [Related]
3. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
4. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.
Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ
Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
[No Abstract] [Full Text] [Related]
7. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection after pediatric living-related liver transplantation--management and risk factors.
Shigeta T; Imadome K; Sakamoto S; Fukuda A; Kakiuchi T; Matsuno N; Tanaka H; Nakazawa A; Kasahara M
Transplant Proc; 2010 Dec; 42(10):4178-80. PubMed ID: 21168657
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
10. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO
Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282
[TBL] [Abstract][Full Text] [Related]
13. [Post-transplant lympho-proliferative disease associated to Epstein-Barr virus].
Sánchez Fructuoso AI
Nefrologia; 2005; 25(1):20-30. PubMed ID: 15789533
[No Abstract] [Full Text] [Related]
14. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
Sirvent N; Reviron D; de Lamballerie X; Michel G
Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
[No Abstract] [Full Text] [Related]
15. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
Petrovic LM
Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
[No Abstract] [Full Text] [Related]
16. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disorders after liver transplantation.
Leblond V; Choquet S
J Hepatol; 2004 May; 40(5):728-35. PubMed ID: 15094218
[No Abstract] [Full Text] [Related]
19. Late Epstein Barr virus reactivation in islet after kidney transplantation.
Cure P; Froud T; Leitão CB; Pileggi A; Tharavanij T; Bernetti K; Baidal DA; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Nov; 86(9):1324-5. PubMed ID: 19005419
[No Abstract] [Full Text] [Related]
20. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
